• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

NeuroPace

MedTech 100 roundup: New all-time best reached

July 6, 2021 By Sean Whooley

Once again, the medtech industry has soared to new heights, eclipsing its all-time best performance by the tiniest of margins. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week (July 2) at 114.59 points. It was just 0.01 points ahead of the 114.58-point mark set in […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Initial Public Offering (IPO), Mergers & Acquisitions, Wall Street Beat Tagged With: belluscura, CMR Surgical, echonous, MedTech 100 Index, Medtronic, NeuroPace, Outset Medical, Teleflex

NeuroPace wins five-year $9.3M grant from NIH

June 30, 2021 By Danielle Kirsh

NeuroPace today announced that it has received a $9.3 million National Institutes of Health grant to study Lennox-Gastaut Syndrome treatment. The NIH — through the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative — will provide up to $9.3 million over a five-year period to evaluate the use of Mountain View, Calif.-based NeuroPace’s RNS neuromodulation […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Neuromodulation/Neurostimulation Tagged With: NeuroPace

MedTech 100 roundup: New heights reached again

April 26, 2021 By Sean Whooley

One week after recording its all-time best performance, the medtech industry again topped itself, storming even further ahead. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — has been on the rise since April began, with last week’s mark of 112.25 (April 16) representing an all-time best, topping the […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Initial Public Offering (IPO), MassDevice Earnings Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: Abbott, coronavirus, COVID-19, danaher, Edwards Lifesciences, Endeavour Vision, Grail, Illumina Inc., Intuitive Surgical, Johnson & Johnson, MedTech 100 Index, NeuroPace

DeviceTalks Weekly Podcast – iRhythm CEO Mike Coyle, New Podcast!

April 23, 2021 By Tom Salemi

In this podcast, iRhythm CEO Mike Coyle discusses his decision to join the digital health leader in January. Coyle’s had to hit the ground running as iRhythm manages some challenging decisions from regional Medicare payors, but he also sees great opportunity for the company’s Zio platform across the healthcare spectrum. In this conversation, Coyle discusses […]

Filed Under: Cardiovascular, Device Talks Podcasts, Digital Health, Featured, Special Content Tagged With: DeviceTalks Weekly, Emergent BioSolutions, Intuitive Surgical, iRhythm Technologies Inc., Medtronic, NeuroPace, Stryker, Zimmer Biomet

NeuroPace shares take off on first day of trading

April 22, 2021 By Sean Whooley

Epilepsy treatment developer NeuroPace (NSDQ:NPCE) shares skyrocketed today during its first day of trading on the Nasdaq market. Mountain View, Calif.-based NeuroPace shares were trading up 37.4% at $23.35 per share in mid-afternoon trading today. The company announced last month that it filed with the SEC to raise up to $75 million in an initial […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Initial Public Offering (IPO), Neurological, Neuromodulation/Neurostimulation, Wall Street Beat Tagged With: NeuroPace

MedTech 100 roundup: Heading back to previous heights?

April 5, 2021 By Sean Whooley

Although March brought on tough times for top stocks in the medtech industry, April is already showing signs of a rebound. The year’s strong start, during which MassDevice‘s MedTech 100 index notched an all-time best of 110.96 points (Feb. 15) came to an end later that month and carried over into March, with the index hitting its lowest […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Initial Public Offering (IPO), Mergers & Acquisitions, Wall Street Beat Tagged With: 3m, Abbott, BD, Corvida Medical, Fresenius Kabi, Grail, Illumina Inc., Medtronic, Merit Medical Systems, NeuroPace

NeuroPace files for $75M IPO

March 29, 2021 By Sean Whooley

Refractory focal epilepsy treatment developer NeuroPace last week filed with the SEC to raise up to $75 million in an initial public offering. Mountain View, Calif-based NeuroPace develops the RNS system, which it touts as the world’s only closed-loop brain-responsive neurostimulation system designed to prevent seizures at their source. The RNS system includes a neurostimulator, […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Initial Public Offering (IPO), Neurological, Neuromodulation/Neurostimulation, Research & Development, Wall Street Beat Tagged With: NeuroPace

DTW Podcast: KCK’s Long says deals getting done during COVID era

September 8, 2020 By Tom Salemi

In this week’s DeviceTalks Weekly Podcast, Karen Long, managing director at KCK Group, says startups looking for funding have an opportunity to catch the eye and ear of investors. KCK, an active medtech investor, has been involved in two sizable investments this summer including Aerin Medical and NeuroPace. Both were portfolio companies, but Long says […]

Filed Under: Blog, Business/Financial News, Device Talks Podcasts, Featured Tagged With: Aerin Medical, DeviceTalks Weekly, IBM, Medtronic, NeuroPace, Thrive Earlier Detection Corp.

NeuroPace raises $67M for RNS system

August 31, 2020 By Sean Whooley

NeuroPace announced today that it raised $67 million for its RNS system for treating refractory focal epilepsy. Accelmed Partners led the round, while an unnamed strategic investor, Revelation Partners, Soleus Capital and returning investors KCK Group and OrbiMed Advisors also participated, according to a news release. Mountain View, Calif-based NeuroPace’s financing includes $33 million in […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Neurological, Neuromodulation/Neurostimulation Tagged With: NeuroPace

NeuroPace wins FDA approval of MRI labeling for its neurostim system

March 9, 2020 By Sean Whooley

NeuroPace announced today that FDA approval of MRI labeling for its RNS system for people living with seizures that do not respond to medication. The Mountain View, Calif.–based company touts its RNS system as the world’s only closed-loop brain-responsive neurostimulation system designed to prevent seizures at their source. It includes a neurostimulator, leads placed at […]

Filed Under: Featured, Food & Drug Administration (FDA), Neurological, Neuromodulation/Neurostimulation, Regulatory/Compliance Tagged With: FDA, NeuroPace

The 10 greatest medtech advances of the 2010s

January 2, 2020 By Chris Newmarker

From disposable endoscopes to TAVR to robotic surgery, there’s a whole host of medtech advances widely available now that weren’t around much 10 years ago. “In terms of technological advances, I would put this past decade as one of the most important for medical technology. From connected devices and robotics, to advances in material sciences […]

Filed Under: Business/Financial News, Cardiovascular, Diabetes, Digital Health, Drug-Device Combinations, Endoscopic, Featured, Neuromodulation/Neurostimulation, News Well, Orthopedics, Regenerative Medicine, Robotics, Surgical Tagged With: 3D printing, Abbott, artificial intelligence, Bigfoot Biomedical, Boston Scientific, Carbon, Edwards Lifesciences, Frequency Therapeutics, Insulet, Johnson & Johnson, Medtronic, NeuroPace, Nevro Corp., robot-assisted, Smith & Nephew, Stryker, tavr

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS